Scoop has an Ethical Paywall
Boehringer Ingelheim applies for clearance to acquire Merial
Boehringer Ingelheim applies for clearance to acquire Merial from Sanofi
The Commerce Commission has received an application from Boehringer Ingelheim International GmbH seeking clearance to acquire 100% of the shares and assets in Merial, the animal health business of Sanofi SA.
Boehringer Ingelheim and Sanofi are global manufacturers of pharmaceutical and vitamin products for humans and for animals, which they each distribute in New Zealand.
While Boehringer Ingelheim’s clearance application relates only to animal health products, the Commission will also consider whether the proposed global transaction might impact on competition in any other markets in New Zealand.
A public version of the clearance application is available on the Commission’sClearances Register.
ends
Bill Bennett: Download Weekly - Starlink direct-to-mobile passes US regulatory hurdle
Plumbers Gasfitters and Drainlayers Board: Plumbers, Gasfitters And Drainlayers Board Drops ‘Journeyman’ And ‘Tradesman’ Names
ERANZ: Electricity Saving Coaching Service To Launch In Wairoa
SolarZero Affected Staff: SolarZero Staff Are Demanding Answers After The Company Went Into Liquidation
Tātau Tātau O Te Wairoa: Guidance To Save Local Newspapers Amid NZME Closures
Commerce Commission: Systemic Breaches Of Consumer Law Lead To $1.5million Fine For Kiwibank
